Reports & Research

The 2026 Commercial Trade & Distribution White Paper provides a strategic framework for building and optimizing high-performing pharmaceutical Trade organizations. Drawing on decades of industry experience and insights from Trade leaders across the pharmaceutical ecosystem, it highlights best practices, key performance indicators (KPIs), governance models, and performance measures that help manufacturers strengthen commercial execution, improve patient access, and prepare for successful product launches. 

The 2024 Specialty Pharmacy Manufacturer Engagement Report, provides an independent assessment of how pharmaceutical manufacturers engage with Specialty Pharmacies (SPPs) as perceived by the SPPs themselves.  The report provides key insights to help pharmaceutical manufacturers enhance their engagement with SPPs to improve patient outcomes and drive better business performance.

Explore the 2023 report revealing the impact of state regulations on prescription drug therapy access and affordability.